MCRB earnings date and last-quarter result: last quarter beat, P/E -1.02. Updated 2026-07-23.
Seres Therapeutics (MCRB) Research Hub
Seres Therapeutics (MCRB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.98 USD (-5.26%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.02, market cap 0.05B. This hub links to the full technical, earnings and options research available for MCRB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.98 USD (-5.26%) |
| 52-week range | 1.98 USD – 8.25 USD |
| Trend regime | Range |
| 14-day RSI | 14.6 (Oversold) |
| Trailing P/E | -1.02 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for MCRB
Covered Call on MCRB: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MCRB: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MCRB: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
MCRB technical analysis: range, last 1.98 USD, RSI 14.6, 52w range 1.98 USD–8.25 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MCRB in?
Seres Therapeutics (MCRB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MCRB in an uptrend or downtrend?
As of 2026-10-26, MCRB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MCRB's trailing P/E ratio?
MCRB's trailing P/E is -1.02, with a market cap of 0.05B. See the earnings research page for full valuation detail.